Literature DB >> 2790824

Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.

J Klominek1, K H Robért, A Hjerpe, B Wickström, G Gahrton.   

Abstract

Two cell lines with different in vitro growth patterns were established from the pleural fluid of a patient with malignant epithelial pleural mesothelioma. The cell line established in RPMI 1640 supplemented with human AB serum had an epithelial morphology, while the cell line established in fetal calf serum-supplemented medium had a fibroblast-like morphology. Exposure of the fibroblast-like cell line to human AB serum-containing medium resulted in a nearly complete transformation of the morphology to the epithelial-like phenotype, and the epithelial-like cell line changed its phenotype to fibroblast-like upon exposure to fetal calf serum-supplemented medium. Both cell lines formed colonies in soft agarose and secreted hyaluronic acid into the culture medium. In both cell lines all the metaphases studied lacked chromosomes 5 and 9, demonstrating the same clonal origin. However, one marker and a missing chromosome 11 were found only in the fibroblast-like cell line. We conclude that human AB serum supplement can be used for the establishment of human tumor cell lines, and that the choice of serum can affect the in vitro morphology of the established mesothelioma cell lines. The mechanisms behind the different growth patterns seem to be a selective stimulation of different subpopulations of malignant cells as well as induction of changes in the morphology of individual cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790824

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship.

Authors:  A Syrokou; G Tzanakakis; T Tsegenidis; A Hjerpe; N K Karamanos
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

2.  Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.

Authors:  Z Liu; J Klominek
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

3.  Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line.

Authors:  Iwao Ishiwata; Emiko Ishiwata; Takashi Hirano
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

4.  Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure.

Authors:  Gustav Nilsonne; Eric Olm; Adam Szulkin; Filip Mundt; Agnes Stein; Branka Kocic; Anna-Klara Rundlöf; Aristi P Fernandes; Mikael Björnstedt; Katalin Dobra
Journal:  J Exp Clin Cancer Res       Date:  2009-06-29

5.  Establishment and characterization of a human malignant mesothelioma cell line (HMMME).

Authors:  Isamu Ishiwata; Chieko Ishiwata; Mitsuru Anzo; Rie Minami; Kazushige Kiguchi; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2003-12       Impact factor: 4.174

6.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

7.  Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains.

Authors:  F Zong; E Fthenou; J Castro; B Péterfia; I Kovalszky; L Szilák; G Tzanakakis; K Dobra
Journal:  Cell Prolif       Date:  2009-10-13       Impact factor: 6.831

8.  Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.

Authors:  Fang Zong; Eleni Fthenou; Nina Wolmer; Péter Hollósi; Ilona Kovalszky; László Szilák; Carolin Mogler; Gustav Nilsonne; Georgios Tzanakakis; Katalin Dobra
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

9.  The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

Authors:  J E Nutt; A R A Razak; K O'Toole; F Black; A E Quinn; A H Calvert; E R Plummer; J Lunec
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

10.  Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

Authors:  Adam Szulkin; Gustav Nilsonne; Filip Mundt; Agata M Wasik; Pega Souri; Anders Hjerpe; Katalin Dobra
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.